Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Tesamorelin Vial Dosing: Full Comparison

2mg 2mL 1mg/mL 1mg 1mL 2 Standard clinical dose. Short vial lifespan, suitable for testing protocols or single-week trials 0.5mg 0.5mL 4 Common research dose for cognitive or metabolic studies. Balances efficacy and side effect minimisation 0.2mg 0.2mL 10 Low-

This comparison does not assign a generated winner or score.

  • 2mg
  • 2mL
  • 1mg/mL
  • 1mg
  • 1mL
  • 2
  • Standard clinical dose. Short vial lifespan, suitable for testing protocols or single-week trials
  • 0.5mg
  • 0.5mL
  • 4
  • Common research dose for cognitive or metabolic studies. Balances efficacy and side effect minimisation
  • 0.2mg
  • 0.2mL
  • 10
  • Low-dose protocol. Extends vial use but requires precise syringe measurement
  • 5mg
  • 5mL
  • 5
  • Larger vial reduces per-dose cost but increases contamination risk through repeated access
  • 2.5mL
  • 2mg/mL
  • Higher concentration. Difficult to measure accurately below 0.1mL, not recommended for doses under 0.5mg
  • 4mL
  • 0.5mg/mL
  • Dilute solution. Easier measurement for lower doses but requires larger draw volumes
More references

Related material